3 documents found, page 1 of 1
Controversies in myopia control treatment: what does it mean for future research?
Lança, Carla; Repka, Michael X.; Grzybowski, AndrzejPurpose: Treatment of myopia has been informed by more than 3 decades of clinical trials and other observations. However, controversies regarding myopia control remain, such as when to stop treatment and what is the long-term efficacy of treatment. This perspective aims to describe clinically relevant and current controversies regarding myopia treatment. Design: Perspective. Methods: We reviewed clinical trial ...
Myths in myopia epidemiology and treatment
Lança, Carla; Repka, Michael X.; Grzybowski, AndrzejPracticing evidence-based medicine requires constant effort to acquire, assess, and implement new knowledge that improves our care. Since 2013, more than 1000 publications per year have discussed myopia,1 many challenging existing medical beliefs. As in other areas of medicine, ophthalmologists are expected to translate new knowledge into their clinical practice as well as manage their demanding clinical schedu...
Topical review: studies on management of myopia progression from 2019 to 2021
Lança, Carla; Repka, Michael X.; Grzybowski, AndrzejMyopia is a common eye condition that increases the risk of sight-threatening complications. Each additional diopter increases the chance of complications. The purpose of this review is to make an overview of myopia control treatment options for children with myopia progression. In this non-systematic review, we searched PubMed and Cochrane databases for English-language studies published from 2019 through Sept...